Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - KEMPHARM, INC | ex_97238.htm |
| EX-31.2 - EXHIBIT 31.2 - KEMPHARM, INC | ex_97236.htm |
| EX-31.1 - EXHIBIT 31.1 - KEMPHARM, INC | ex_97235.htm |
| 10-Q - FORM 10-Q - KEMPHARM, INC | kmph20170930_10q.htm |
Exhibit 32.1
CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of KemPharm, Inc., (the “Company”) for the quarterly period ended September 30, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Travis C. Mickle, Principal Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
|
1. |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
2. |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
November 9, 2017 |
/s/ Travis C. Mickle | ||
|
Name: |
Travis C. Mickle, Ph.D. |
||
|
Title: |
President and Chief Executive Officer (Principal Executive Officer) |
||
| The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, is not being "filed" by the Company as part of the Report or as a separate disclosure document and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing. | |||